Differential immunomodulatory effect of PARP inhibition in BRCA1 deficient and competent tumor cells.
Alvarado-Cruz I, Mahmoud M, Khan M, Zhao S, Oeck S, Meas R, Clairmont K, Quintana V, Zhu Y, Porciuncula A, Wyatt H, Ma S, Shyr Y, Kong Y, LoRusso PM, Laverty D, Nagel ZD, Schalper KA, Krauthammer M, Sweasy JB.
Alvarado-Cruz I, et al. Among authors: quintana v.
Biochem Pharmacol. 2021 Feb;184:114359. doi: 10.1016/j.bcp.2020.114359. Epub 2020 Dec 4.
Biochem Pharmacol. 2021.
PMID: 33285109
Free PMC article.